Cisplatin Treatment Options

A collection of 1423 research studies where Cisplatin is the interventional treatment. These studies are located in the United States. Cisplatin is used for conditions such as Head and Neck Cancer, Lung Cancer and Non-small Cell Lung Cancer.

Home

All Treatments

Cisplatin

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Trial

Type 2 Diabetes Clinical Trial

Recruiting

Can changing your breakfast improve your type 2 diabetes? If you have an HbA1C of 7.0% or higher, you are invited to participate in an online study at the University of Michigan.

Conditions:

Type 2 Diabetes

Diabetes Mellitus Type 2 in Obese

Diabetes Type Two

Type 2 Diabetes Mellitus

Diabete Type 2

Learn More

Featured Offer

Lose Weight with GLP-1 Medications

Recruiting

Policy Lab has partnered with CareGLP to offer trusted access to GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.

As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery

NCT04991025

Recruiting

The purpose of the study is to explore adding the study drug certolizumab to standard chemotherapy as it may reduce the inflammation caused by the cancer and make the chemotherapy more effective in shrinking the cancer. This study will examine whether adding certolizumab to the usual treatment approach is better than, the same as, or worse than the usual approach alone.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/18/2024

Locations: Memorial Sloan Kettering at Basking Ridge Limited Protocol Activities, Basking Ridge, New Jersey +6 locations

Conditions: Lung Cancer, Lung Cancer Stage II, Lung Cancer Stage III

Learn More ›

HOT: HIPEC in Ovarian Cancer as Initial Treatment

NCT02124421

Active Not Recruiting

Community hospital based phase II (prospective randomized) study to evaluate the toxicity of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in newly diagnosed, otherwise untreated, advanced stage (stage III/IV) epithelial ovarian, fallopian tube, and primary peritoneal cancer.

Gender:

FEMALE

Ages:

Between 18 years and 80 years

Trial Updated:

11/18/2024

Locations: Mercy Medical Center, Baltimore, Maryland

Conditions: Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma, Ovarian Carcinoma, Fallopian Tube Carcinoma

Learn More ›

Afatinib With CT and RT for EGFR-Mutant NSCLC

NCT01553942

Active Not Recruiting

This research study is a Phase II clinical trial. Phase II clinical trials test the effectiveness of an investigational drug to learn whether the drug works in treating a specific cancer. "Investigational" means that the drug is still being studied and that study doctors are trying to find out more about it-such as the safest dose to use, the side effects it may cause, and if the drug is effective for treating different types of cancer. It also means that the FDA has not yet approved the drug fo... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/18/2024

Locations: Dana-Farber Cancer Institute, Boston, Massachusetts +1 locations

Conditions: Lung Cancer

Learn More ›

An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)

NCT02477826

Completed

The purpose of this study is to show that Nivolumab, or Nivolumab plus Ipilimumab, or Nivolumab plus Platinum-Doublet Chemotherapy improves progression free survival and/or overall survival compared with chemotherapy in patients with advanced lung cancer.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/16/2024

Locations: Southern Cancer Center, Inc., Mobile, Alabama +289 locations

Southern Cancer Center, Inc., Mobile, Alabama

Local Institution - 0017, San Francisco, California

Local Institution - 0021, New Haven, Connecticut

Local Institution - 0001, Atlanta, Georgia

Local Institution - 0013, Marietta, Georgia

Local Institution - 0004, Lexington, Kentucky

Local Institution - 0115, Saint Louis, Missouri

Local Institution - 0005, Buffalo, New York

Local Institution - 0019, New York, New York

Local Institution - 0014, Cleveland, Ohio

Local Institution - 0009, Columbus, Ohio

Local Institution - 0007, Allentown, Pennsylvania

Local Institution - 0075, Langhorne, Pennsylvania

Local Institution - 0299, Philadelphia, Pennsylvania

Local Institution - 0012, Philadelphia, Pennsylvania

Local Institution - 0015, Sayre, Pennsylvania

Local Institution - 0008, Charleston, South Carolina

Local Institution - 0080, Greenville, South Carolina

Local Institution - 0010, Greenville, South Carolina

Local Institution - 0020, Nashville, Tennessee

Local Institution - 0306, Dallas, Texas

Local Institution - 0003, Dallas, Texas

Local Institution - 0102, Houston, Texas

Local Institution - 0011, Salt Lake City, Utah

Local Institution - 0074, Kennewick, Washington

Local Institution - 0170, Berazategui, Buenos Aires

Local Institution - 0171, Capital Federal, Buenos Aires

Local Institution - 0172, Ciudad Autonoma De Buenos Aire, Buenos Aires

Local Institution - 0176, Ciudad de Buenos Aires, Buenos Aires

Local Institution - 0296, Mar Del Plata, Buenos Aires

Local Institution - 0177, Viedma, RIO Negro

Local Institution - 0130, San Miguel de Tucuman, Tucuman

Local Institution - 0268, Cordoba, Not set

Local Institution - 0272, Córdoba, Not set

Local Institution - 0297, Córdoba, Not set

Local Institution - 0182, Garran, Australian Capital Territory

Local Institution - 0301, Blacktown, New South Wales

Local Institution - 0300, Gosford, New South Wales

Local Institution - 0045, Brisbane, Queensland

Local Institution - 0046, Elizabeth Vale, South Australia

Local Institution - 0043, Clayton, Victoria

Local Institution - 0042, Fitzroy, Victoria

Local Institution - 0180, Perth, Western Australia

Local Institution - 0040, Murdoch, Not set

Local Institution - 0183, North Tamworth, Not set

Local Institution - 0241, Graz, Not set

Local Institution - 0240, Vienna, Not set

Local Institution - 0239, Wels, Not set

Local Institution - 0121, Roeselare, West-Vlaanderen

Local Institution - 0030, Edegem, Not set

Local Institution - 0031, Gent, Not set

Local Institution - 0034, Gilly, Not set

Local Institution - 0117, Hasselt, Not set

Local Institution - 0033, Sint Niklaas, Not set

Local Institution - 0125, Salvador, Bahia

Local Institution - 0124, Ijui, RIO Grande DO SUL

Local Institution - 0123, Porto Alegre, Rio Grande Do Sul

Local Institution - 0127, Barretos, Sao Paulo

Local Institution - 0129, Rio De Janeiro, Not set

Local Institution - 0144, Sao Paulo, Not set

Local Institution - 0126, Sao Paulo, Not set

Local Institution - 0128, Sao Paulo, Not set

Local Institution - 0103, Edmonton, Alberta

Local Institution - 0290, St. John's, Newfoundland and Labrador

Local Institution - 0104, London, Ontario

Local Institution - 0122, Montreal, Quebec

Local Institution - 0106, Quebec City, Quebec

Local Institution - 0107, Rimouski, Quebec

Local Institution - 0291, Sherbrooke, Quebec

Local Institution - 0292, Trois-Rivieres, Quebec

Local Institution - 0302, Quebec, Not set

Local Institution - 0173, Santiago, Metropolitana

Local Institution - 0131, Santiago, Región Metropolitana De Santiago

Local Institution - 0174, Vina Del Mar, Valparaiso

Local Institution - 0380, Hefei, Anhui

Local Institution - 0313, Beijing, Beijing

Local Institution - 0315, Beijing, Beijing

Local Institution - 0316, Beijing, Beijing

Local Institution - 0314, Beijing, Beijing

Local Institution - 0365, Chongqing, Chongqing

Local Institution - 0364, Chongqing, Chongqing

Local Institution - 0378, Chongqing, Chongqing

Local Institution - 0322, Guangzhou, Guangdong

Local Institution - 0372, Guangzhou, Guangdong

Local Institution - 0319, Guanzhou, Guangdong

Local Institution - 0323, Haikou, Hainan

Local Institution - 0325, Haerbin, Heilongjiang

Local Institution - 0324, Zhengzhou, Henan

Local Institution - 0379, Zhengzhou, Henan

Local Institution - 0375, Wuhan, Hubei

Local Institution - 0362, Changsha, Hunan

Local Institution - 0347, Nanchang, Jiangxi

Local Institution - 0329, Changchun, Jilin

Local Institution - 0361, Changchun, Jilin

Local Institution - 0359, Shenyang, Liaoning

Local Institution - 0371, Xi'an, Shaanxi

Local Institution - 0333, Xi'an, Shan3xi

Local Institution - 0360, Qingdao, Shandong

Local Institution - 0334, Shanghai, Shanghai

Local Institution - 0376, Chengdu, Sichuan

Local Institution - 0373, Tianjin, Tianjin

Local Institution - 0340, Urumqi, Xinjiang

Local Institution - 0343, Hangzhou, Zhejiang

Local Institution - 0370, Hangzhou, Zhejiang

Local Institution - 0342, Hangzhou, Zhejiang

Local Institution - 0328, Changsha, Not set

Local Institution - 0341, Hangzhou, Not set

Local Institution - 0345, Kunming, Not set

Local Institution - 0336, Shanghai, Not set

Local Institution - 0337, Shanghai, Not set

Local Institution - 0374, Shantou, Not set

Local Institution - 0273, Pereira, Risaralda

Local Institution - 0237, Bogota, Not set

Local Institution - 0238, Bogota, Not set

Local Institution - 0282, Medellin, Not set

Local Institution - 0112, Hradec Kralove, Not set

Local Institution - 0113, Olomouc, Not set

Local Institution - 0111, Praha 4, Not set

Local Institution - 0232, Pribram, Not set

Local Institution - 0270, Oulu, Not set

Local Institution - 0271, Turku, Not set

Local Institution - 0222, Bron, Rhône

Local Institution - 0216, ANGERS Cedex 2, Not set

Local Institution - 0229, Besançon Cedex, Not set

Local Institution - 0283, Caen, Not set

Local Institution - 0218, Creteil, Not set

Local Institution - 0228, Limoges, Not set

Local Institution - 0215, Marseille Cedex 20, Not set

Local Institution - 0230, Paris, Not set

Local Institution - 0227, Pessac, Not set

Local Institution - 0223, Rennes, Not set

Local Institution - 0225, Rouen, Not set

Local Institution - 0221, Saint Priest En Jarez, Not set

Local Institution - 0217, Saint-herblain Cedex, Not set

Local Institution - 0224, Strasbourg, Not set

Local Institution - 0226, Toulon, Not set

Local Institution - 0231, Magdeburg, Sachsen-Anhalt

Local Institution - 0213, Bad Berka, Not set

Local Institution - 0208, Berlin, Not set

Local Institution - 0205, Essen, Not set

Local Institution - 0210, Frankfurt, Not set

Local Institution - 0211, Gera, Not set

Local Institution - 0203, Grosshansdorf, Not set

Local Institution - 0209, Halle, Not set

Local Institution - 0202, Heidelberg, Not set

Local Institution - 0214, Hemer, Not set

Local Institution - 0206, Immenstadt, Not set

Local Institution - 0204, Muenchen, Not set

Local Institution - 0201, Stuttgart, Not set

Local Institution - 0212, Wiesbaden, Not set

Local Institution - 0094, Athens, Attikí

Local Institution - 0095, Heraklion, Not set

Local Institution - 0190, Neo Faliro, Not set

Local Institution - 0101, Thessaloniki, Not set

Local Institution - 0025, Budapest, Not set

Local Institution - 0024, Budapest, Not set

Local Institution - 0026, Matrahaza, Not set

Local Institution - 0054, Dublin 8, Dublin

Local Institution - 0053, Beaumont, Not set

Local Institution - 0055, Galway, Not set

Local Institution - 0100, Limerick, Not set

Local Institution - 0187, Jerusalem, Not set

Local Institution - 0186, Kfar-saba, Not set

Local Institution - 0185, Petach Tikva, Not set

Local Institution - 0184, Tel-hashomer, Not set

Local Institution - 0188, Zerifin, Not set

Local Institution - 0083, Milan, Lombardia

Azienda Ospedaliera Moscati, Avellino, Not set

Local Institution - 0179, Bergamo, Not set

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Not set

Local Institution - 0084, Livorno, Not set

Policlinico G. Martino, Messina, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Not set

Istituto Nazionale Tumori Fondazione Pascale, Napoli, Not set

Local Institution - 0087, Perugia, Not set

Ospedale Santa Maria delle Croci, Ravenna, Not set

Ifo-Istituto Regina Elena, Roma, Not set

Local Institution - 0089, Roma, Not set

Local Institution - 0085, Terni, Not set

Local Institution - 0153, Nagoya-shi, Aichi

Local Institution - 0152, Nagoya, Aichi

Local Institution - 0148, Kashiwa-shi, Chiba

Local Institution - 0159, Matsuyama, Ehime

Local Institution - 0160, Fukuoka-shi, Fukuoka

Local Institution - 0259, Kurume-shi, Fukuoka

Local Institution - 0255, Ota-shi, Gunma

Local Institution - 0258, Hiroshima-shi, Hiroshima

Local Institution - 0163, Sapporo-shi, Hokkaido

Local Institution - 0253, Sapporo-shi, Hokkaido

Local Institution - 0252, Akashi-shi, Hyogo

Local Institution - 0156, Kobe-shi, Hyogo

Local Institution - 0146, Kanazawa-shi, Ishikawa

Local Institution - 0161, Yokohama-shi, Kanagawa

Local Institution - 0150, Yokohama-Shi, Kanagawa

Local Institution - 0275, Natori-shi, Miyagi

Local Institution - 0254, Sendai-shi, Miyagi

Local Institution - 0145, Sendai-shi, Miyagi

Local Institution - 0164, Niigata-shi, Niigata

Local Institution - 0158, Kurashiki-shi, Okayama

Local Institution - 0155, Hirakata-shi, Osaka

Local Institution - 0154, Osaka-shi, Osaka

Local Institution - 0251, Osakasayama-shi, Osaka

Local Institution - 0257, Takatsuki-shi, Osaka

Local Institution - 0353, Hidaka-shi, Saitama

Local Institution - 0256, Kitaadachi-gun, Saitama

Local Institution - 0151, Sunto-gun, Shizuoka

Local Institution - 0147, Chuo-ku, Tokyo

Local Institution - 0149, Koto-ku, Tokyo

Local Institution - 0278, Shinjuku-ku, Tokyo

Local Institution - 0157, Wakayama-shi, Wakayama

Local Institution - 0354, Ube-shi, Yamaguchi

Local Institution - 0260, Chiba, Not set

Local Institution - 0165, Okayama, Not set

Local Institution - 0162, Tokyo, Not set

Local Institution - 0136, Seongnam-si, Kyǒnggi-do

Local Institution - 0249, Cheongju-si, Not set

Local Institution - 0133, Gangnam-gu, Not set

Local Institution - 0132, Seoul, Not set

Local Institution - 0135, Seoul, Not set

Local Institution - 0287, Beirut, Not set

Local Institution - 0286, Beirut, Not set

Local Institution - 0196, Df, Distrito Federal

Local Institution - 0193, Mexico, Distrito Federal

Local Institution - 0198, Cuautitlan, Estado DE Mexico

Local Institution - 0197, Guadalajara, Jalisco

Local Institution - 0191, Zapopan, Jalisco

Local Institution - 0267, Morelia, Michoacan

Local Institution - 0277, Monterrey, Nuevo Leon

Local Institution - 0303, Merida, Yucatán

Local Institution - 0192, Chihuahua, Not set

Local Institution - 0195, San Luis Potosi, Not set

Local Institution - 0236, San Luis Potosi, Not set

Local Institution - 0194, Toluca, Not set

Local Institution - 0036, Amsterdam, Not set

Local Institution - 0189, Amsterdam, Not set

Local Institution - 0169, Breda, Not set

Local Institution - 0037, Rotterdam, Not set

Local Institution - 0039, Veldhoven, Not set

Local Institution - 0262, Lima, Not set

Local Institution - 0263, Lima, Not set

Local Institution - 0350, Lima, Not set

Local Institution - 0261, Lima, Not set

Local Institution - 0351, Lima, Not set

Local Institution - 0060, Bydgoszcz, Not set

Local Institution - 0058, Gdansk, Not set

Local Institution - 0063, Gdynia, Not set

Local Institution - 0072, Gliwice, Not set

Local Institution - 0057, Lodz, Not set

Local Institution - 0059, Warszawa, Not set

Local Institution - 0070, Wroclaw, Not set

Local Institution - 0167, Craiova, Not set

Local Institution - 0250, Floresti, Not set

Local Institution - 0166, Romania, Not set

Local Institution - 0284, Sector 2, Not set

Local Institution - 0137, Chelyabinsk, Not set

Local Institution - 0142, Kazan, Not set

Local Institution - 0022, Moscow, Not set

Local Institution - 0049, Saint-Petersburg, Not set

Local Institution - 0028, St. Petersburg, Not set

Local Institution - 0027, St. Petersburg, Not set

Local Institution - 0143, Ufa, Not set

Local Institution - 0264, Pretoria, Gauteng

Local Institution - 0234, Sandton, Gauteng

Local Institution - 0233, Saxonwold, Johannesburg, Gauteng

Local Institution - 0305, Vereeniging, Not set

Local Institution - 0064, Majadahonda, Madrid

Local Institution - 0066, Barcelona, Not set

Local Institution - 0067, Barcelona, Not set

Local Institution - 0065, Madrid, Not set

Local Institution - 0069, Sevilla, Not set

Local Institution - 0068, Valencia, Not set

Local Institution - 0243, Basel, Not set

Local Institution - 0246, Chur, Not set

Local Institution - 0244, Lausanne, Not set

Local Institution - 0245, Winterthur, Not set

Local Institution - 0139, Taichung, Not set

Local Institution - 0138, Taipei, Not set

Local Institution - 0140, Taipei, Not set

Local Institution - 0310, Taipei, Not set

Local Institution - 0141, Taoyuan city, Not set

Local Institution - 0266, Middlesborough, Cleveland

Local Institution - 0098, London, Greater London

Local Institution - 0099, Southampton, Hampshire

Local Institution - 0118, Leicester, Leicestershire

Local Institution - 0265, Birmingham, Not set

Local Institution - 0051, Cambridgeshire, Not set

Local Institution - 0109, Edinburgh, Not set

Local Institution - 0097, London, Not set

Local Institution - 0050, London, Not set

Local Institution - 0119, Surrey, Not set

Conditions: Non-Small Cell Lung Cancer

Learn More ›

Gemcitabine-Cisplatin-90Y TARE for Unresectable Intrahepatic Cholangiocarcinoma

NCT02512692

Terminated

The purpose of this study is to determine the safety and maximum tolerated dose (MTD) of 90 Y TARE (Y90) in combination with gemcitabine and cisplatin in patients with unresectable intrahepatic cholangiocarcinoma (ICC).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/15/2024

Locations: Medical University of South Carolina, Charleston, South Carolina

Conditions: Intrahepatic Cholangiocarcinoma

Learn More ›

Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)

NCT04924101

Active Not Recruiting

The purpose of this study is to evaluate the use of investigational agents (MK-4830, boserolimab (MK-5890) and lenvatinib (MK-7902)) in combination with pembrolizumab (MK-3475) and etoposide/platinum chemotherapy for the first-line treatment of participants with extensive-stage small cell Lung Cancer (ES-SCLC). No formal hypothesis testing will be performed for this study.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/15/2024

Locations: Banner MD Anderson Cancer Center ( Site 0102), Gilbert, Arizona +48 locations

Banner MD Anderson Cancer Center ( Site 0102), Gilbert, Arizona

University of Colorado Anschutz Medical Campus ( Site 0104), Aurora, Colorado

Georgia Cancer Specialists ( Site 0106), Atlanta, Georgia

Parkview Research Center at Parkview Regional Medical Center ( Site 0130), Fort Wayne, Indiana

Baptist Health Lexington-Research ( Site 0108), Lexington, Kentucky

MFSMC-HJWCI-Oncology Research ( Site 0128), Baltimore, Maryland

Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0122), Omaha, Nebraska

Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0129), Omaha, Nebraska

Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0114), Mineola, New York

Memorial Sloan Kettering Cancer Center ( Site 0115), New York, New York

Cleveland Clinic-Taussig Cancer Center ( Site 0116), Cleveland, Ohio

UPMC Hillman Cancer Center ( Site 0127), Pittsburgh, Pennsylvania

St Francis Cancer Center-Research Office ( Site 0117), Greenville, South Carolina

Virginia Cancer Institute ( Site 0119), Richmond, Virginia

Klinik Penzing-2. Lungenabteilung ( Site 2101), Vienna, Wien

Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 2100), Wien, Not set

Hamilton Health Sciences-Juravinski Cancer Centre ( Site 2003), Hamilton, Ontario

Kingston Health Sciences Centre-Kingston General Hospital Site ( Site 2005), Kingston, Ontario

St. Marys Hospital Center ( Site 2000), Montreal, Quebec

Jász-Nagykun-Szolnok Megyei Hetényi Géza Kórház-Onkologiai Kozpont ( Site 2800), Szolnok, Jasz-Nagykun-Szolnok

Országos Korányi Pulmonológiai Intézet-XIV. Tüdöbelgyógyászat ( Site 2806), Budapest, Pest

Torokbalint Tudogyogyintezet-Onkopulmonologiai Jarobeteg Centrum ( Site 2801), Törökbálint, Pest

Zala Megyei Szent Rafael Kórház-Pulmonológia ( Site 2805), Zalaegerszeg, Zala

Semmelweis University-Pulmonológiai Klinika ( Site 2802), Budapest, Not set

Rambam Health Care Campus-Oncology ( Site 2600), Haifa, Not set

Shaare Zedek Medical Center ( Site 2602), Jerusalem, Not set

Meir Medical Center ( Site 2601), Kfar Saba, Not set

Rabin Medical Center-Oncology ( Site 2604), Petah Tikva, Not set

Sheba Medical Center-ONCOLOGY ( Site 2603), Ramat Gan, Not set

Ospedale San Raffaele-Oncologia Medica ( Site 2303), Milano, Lombardia

ospedale le scotte-U.O.C. Immunoterapia Oncologica ( Site 2300), Siena, Toscana

Istituto Europeo di Oncologia IRCCS-Divisione di Oncologia Toracica ( Site 2304), Milano, Not set

Chungbuk National University Hospital ( Site 1107), Cheongju-si, Chungbuk

Seoul National University Bundang Hospital ( Site 1104), Seongnam, Kyonggi-do

The Catholic University Of Korea St. Vincent's Hospital ( Site 1106), Suwon-si, Kyonggi-do

Seoul National University Hospital ( Site 1101), Seoul, Not set

Severance Hospital, Yonsei University Health System-Medical oncology ( Site 1105), Seoul, Not set

Asan Medical Center-Department of Oncology ( Site 1103), Seoul, Not set

Samsung Medical Center ( Site 1100), Seoul, Not set

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier, Warszawa, Mazowieckie

Samodzielny Publiczny Zespó Grulicy i Chorób Puc w Olsztynie-Oddzial Onkologii z Pododdzialem Chemi, Olsztyn, Warminsko-mazurskie

Krasnoyarsk Regional Oncology Dispensary, Named after Krizhanovsky ( Site 2708), Krasnoyarsk, Krasnoyarskiy Kray

N.N.Petrov Research Institute of Oncology-Department of Chemotherapy and Innovative Technologies ( S, Saint Petersburg, Sankt-Peterburg

GBUZ "SPb CRPCstmc(o)" ( Site 2705), Saint-Petersburg, Sankt-Peterburg

Scientific research institution of oncology named after N.N. Petrov-Thoracic oncology ( Site 2704), Sankt-Peterburg, Not set

Instituto Catalan de Oncologia - Hospital Duran i Reynals ( Site 2403), L'Hospitalet de Llobregat, Cataluna

Hospital Insular de Gran Canaria ( Site 2402), Las Palmas de Gran Canaria, Las Palmas

Hospital Universitari Vall d'Hebron-Oncology ( Site 2401), Barcelona, Not set

Cantonal Hospital St.Gallen-Oncology & Hematology ( Site 2502), st.Gallen, Sankt Gallen

Conditions: Small Cell Lung Cancer

Learn More ›

Cisplatin + Radiation in SCCHN and Correlation with Oxidative Stress Markers

NCT02994069

Active Not Recruiting

Patients will receive standard of care radiation therapy to the primary tumor of the head and neck and involved nodal metastasis and draining nodal basin and either weekly cisplatin or every 3-week cisplatin in locally advanced SCCHN. The relationship between cisplatin toxicity and the level of reactive oxygen species generated by the drug in subjects with squamous cell carcinoma of the head and neck treated on this trial.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/15/2024

Locations: University of Kentucky, Lexington, Kentucky

Conditions: Carcinoma, Squamous Cell, Head and Neck Cancer

Learn More ›

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

NCT04380636

Active Not Recruiting

The purpose of this study is to assess the efficacy and safety of pembrolizumab in combination with concurrent chemoradiation therapy followed by either pembrolizumab with olaparib placebo (Arm 1) or with olaparib (Arm 2) compared to concurrent chemoradiation therapy followed by durvalumab (Arm 3) in participants with unresectable, locally advanced NSCLC. Arms 1 and 2 will be studied in a double-blind design and Arm 3 will be open-label. The primary hypotheses are: 1. Pembrolizumab with concurr... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/15/2024

Locations: University of South Alabama, Mitchell Cancer Institute ( Site 0003), Mobile, Alabama +204 locations

University of South Alabama, Mitchell Cancer Institute ( Site 0003), Mobile, Alabama

St. Bernards Medical Center ( Site 0089), Jonesboro, Arkansas

St Joseph Heritage Healthcare-Oncology ( Site 0088), Fullerton, California

Long Beach Memorial Medical Center ( Site 0006), Long Beach, California

UCLA Hematology/Oncology - Santa Monica ( Site 0013), Los Angeles, California

St. Joseph Heritage Healthcare Local Lab ( Site 0011), Santa Rosa, California

Torrance Memorial Physician Network / Cancer Center ( Site 0093), Torrance, California

Memorial Regional Hospital-Memorial Cancer Institute ( Site 0095), Hollywood, Florida

Miami VA Healthcare System ( Site 0024), Miami, Florida

Mid Florida Hematology and Oncology Center ( Site 0022), Orange City, Florida

Orlando Health, UF Health Cancer Center Inc ( Site 0092), Orlando, Florida

Fort Wayne Medical Oncology and Hematology ( Site 0094), Fort Wayne, Indiana

Parkview Research Center ( Site 0032), Fort Wayne, Indiana

Franciscan Health Lafayette East ( Site 0031), Lafayette, Indiana

University of Kentucky ( Site 0096), Lexington, Kentucky

Norton Brownsboro Hospital-Norton Cancer Institute - Brownsboro ( Site 0035), Louisville, Kentucky

Pikeville Medical Center ( Site 0036), Pikeville, Kentucky

Massachusetts General Hospital ( Site 0038), Boston, Massachusetts

Henry Ford Hospital ( Site 0045), Detroit, Michigan

VA St. Louis Health Care System ( Site 0047), Saint Louis, Missouri

Washington University Siteman Cancer Center ( Site 0046), Saint Louis, Missouri

CHI Health St. Francis ( Site 0053), Grand Island, Nebraska

Rutgers Cancer Institute of New Jersey ( Site 0054), New Brunswick, New Jersey

The Valley Hospital ( Site 0056), Paramus, New Jersey

Montefiore Einstein Center ( Site 0083), Bronx, New York

Novant Health Presbyterian ( Site 0081), Charlotte, North Carolina

Duke University Medical Center ( Site 0050), Durham, North Carolina

Piedmont Hematology-Oncology Associates ( Site 0080), Winston-Salem, North Carolina

The Lindner Center for Research and Education at The Christ Hospital ( Site 0060), Cincinnati, Ohio

Fox Chase Cancer Center ( Site 0063), Philadelphia, Pennsylvania

Sanford Cancer Center Oncology Clinic ( Site 0066), Sioux Falls, South Dakota

Veterans Affairs Puget Sound Health Care System [Seattle, WA] ( Site 0075), Seattle, Washington

Cancer Care Northwest ( Site 0074), Spokane Valley, Washington

Instituto Médico Río Cuarto ( Site 4003), Río Cuarto, Cordoba

Clinica Adventista Belgrano-Oncology ( Site 4002), Caba, Not set

Queen Elizabeth II Health Sciences Centre ( Site 0100), Halifax, Nova Scotia

Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0102), Montreal, Quebec

CIUSSS Ouest de l Ile - St-Mary s Hospital ( Site 0108), Montreal, Quebec

McGill University Health Center - Research Institute ( Site 0114), Montreal, Quebec

Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0, Quebec, Not set

Centro Investigación del Cáncer James Lind ( Site 0202), Temuco, Araucania

OrlandiOncologia ( Site 0201), Santiago, Region M. De Santiago

Bradfordhill ( Site 0200), Santiago, Region M. De Santiago

Oncocentro ( Site 0203), Vina del Mar, Valparaiso

Bradford Hill Norte ( Site 0204), Antofagasta, Not set

Beijing Cancer Hospital ( Site 3224), Beijing, Beijing

Peking Union Medical College Hospital ( Site 3201), Beijing, Beijing

Cancer Hospital Chinese Academy of Medical Sciences ( Site 3213), Beijing, Beijing

Beijing Cancer Hospital ( Site 3212), Beijing, Beijing

Daping Hospital,Third Military Medical University ( Site 3235), Chongqing, Chongqing

Fujian Provincial Cancer Hospital ( Site 3226), Fuzhou, Fujian

The First Affiliated Hospital of Xiamen University ( Site 3219), Xiamen, Fujian

Peking University Shenzhen Hospital ( Site 3216), Shenzhen, Guangdong

Cancer Hospital Chinese Academy Of Medical Sciences. Shenzhen Center ( Site 3200), Shenzhen, Guangdong

Henan Cancer Hospital ( Site 3205), Zhengzhou, Henan

Wuhan Union Hospital ( Site 3222), Wuhan, Hubei

Hubei Cancer Hospital ( Site 3218), Wuhan, Hubei

Hunan Cancer Hospital ( Site 3238), Changsha, Hunan

Xiangya Hospital of Central South University ( Site 3637), Changsha, Hunan

Second Xiangya Hospital of Central-South University ( Site 3227), Changsha, Hunan

Hunan Cancer Hospital ( Site 3225), Changsha, Hunan

Jiangsu Cancer Hospital ( Site 3234), Nanjing, Jiangsu

The Second Affiliated Hospital of Nanchang University ( Site 3206), Nanchang, Jiangxi

Jilin Cancer Hospital ( Site 3230), Changchun, Jilin

Shanghai Chest Hospital ( Site 3207), Shangai, Shanghai

Zhongshan Hospital Fudan University ( Site 3220), Shanghai, Shanghai

Shanghai Pulmonary Hospital ( Site 3203), Shanghai, Shanghai

West China Hospital of Sichuan University ( Site 3202), Chengdu, Sichuan

Tianjin Medical University Cancer Institute & Hospital ( Site 3204), Tianjin, Tianjin

The 1st Affil Hosp of College of Medicine, Zhejiang Univ ( Site 3232), Hangzhou, Zhejiang

Masarykuv onkologicky ustav ( Site 2206), Brno, Brno-mesto

Fakultni nemocnice Ostrava ( Site 2201), Ostrava, Ostrava Mesto

Fakultni nemocnice Kralovske Vinohrady-Radioterapeuticka a onkologicka klinika ( Site 2200), PRague, Praha 10

Fakultni nemocnice v Motole ( Site 2210), Praha, Praha, Hlavni Mesto

Nemocnice Na Plesi s.r.o. ( Site 2202), Nova Ves pod Plesi, Pribram

Krajska nemocnice Liberec, a.s. ( Site 2209), Liberec, Not set

Vseobecna fakultni nemocnice v Praze ( Site 2208), Praha 2, Not set

Nemocnice Na Bulovce ( Site 2205), Praha 8, Not set

North Estonia Medical Centre Foundation ( Site 1601), Tallin, Harjumaa

Tartu University Hospital ( Site 1600), Tartu, Tartumaa

Clinique Clairval ( Site 0802), Marseille, Bouches-du-Rhone

C.H.R.U. de Brest - Hopital Morvan ( Site 0806), Brest, Bretagne

Centre Hospitalier Annecy Genevois ( Site 0811), Epagny Metz Tessy, Haute-Savoie

Clinique Teissier Groupe ( Site 0808), Valenciennes, Nord

Hopital Avicenne ( Site 0803), Bobigny, Seine-Saint-Denis

Clinique de l'Europe-Service de pneumologie ( Site 0816), Amiens, Somme

H.I.A. Sainte-Anne ( Site 0815), Toulon, Var

CHD Vendee ( Site 0807), La Roche sur Yon, Vendee

Universitätsmedizin Göttingen - Georg-August-Universität ( Site 0917), Göttingen, Niedersachsen

Johannes Wesling Klinikum Minden ( Site 0908), Minden, Nordrhein-Westfalen

GEHO Muenster ( Site 0910), Muenster, Nordrhein-Westfalen

Johanna Etienne Hospital-Klinik für Onkologie ( Site 0916), Neuss, Nordrhein-Westfalen

LungenClinic Grosshansdorf GmbH ( Site 0901), Grosshansdorf, Schleswig-Holstein

Zentralklinik Bad Berka GmbH ( Site 0905), Bad Berka, Thuringen

Universitaetsklinikum Jena ( Site 0911), Jena, Thuringen

Charite-Universitaetsmedizin Berlin Campus Virchow-Klinikum ( Site 0900), Berlin, Not set

Katholisches Marienkrankenhaus gGmbH ( Site 0902), Hamburg, Not set

Bacs-Kiskun Megyei Korhaz-Onkoradiologiai Kozpont ( Site 2302), Kecskemét, Bacs-Kiskun

Bekes Megyei Kozponti Korhaz - Pandy Kalman Tagkorhaza ( Site 2303), Gyula, Bekes

Petz Aladar Megyei Oktato Korhaz ( Site 2306), Gyor, Gyor-Moson-Sopron

Orszagos Koranyi Pulmonologiai Intezet ( Site 2305), Budapest, Not set

Országos Korányi Pulmonológiai Intézet-VI. Tüdöbelosztály és Bronchológia ( Site 2309), Budapest, Not set

Azienda Ospedaliera Umberto I- Torrette ( Site 1009), Torrette, Ancona

Azienda Ospedaliero Universitaria Careggi ( Site 1001), Florence, Firenze

Istituto Clinico Humanitas Research Hospital ( Site 1000), Rozzano, Lombardia

Azienda Ospedaliera Vito Fazzi ( Site 1003), Lecce, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 1008), Milano, Not set

Policlinico di Modena ( Site 1007), Modena, Not set

Policlinico Agostino Gemelli ( Site 1002), Roma, Not set

A.O.U. Santa Maria della Misericordia di Udine ( Site 1004), Udine, Not set

Kurume University Hospital ( Site 3112), Kurume, Fukuoka

Kobe Minimally Invasive Cancer Center ( Site 3100), Kobe, Hyogo

Kanagawa Cancer Center ( Site 3101), Yokohama, Kanagawa

Kansai Medical University Hospital ( Site 3103), Hirakata, Osaka

Osaka Medical and Pharmaceutical University Hospital ( Site 3110), Takatsuki, Osaka

National Hospital Organization Kyushu Cancer Center ( Site 3104), Fukuoka, Not set

Niigata Cancer Center Hospital ( Site 3109), Niigata, Not set

Osaka International Cancer Institute ( Site 3106), Osaka, Not set

Juntendo University Hospital ( Site 3111), Tokyo, Not set

Tokyo Metropolitan Komagome Hospital ( Site 3108), Tokyo, Not set

The Cancer Institute Hospital of JFCR ( Site 3107), Tokyo, Not set

Showa University Hospital ( Site 3105), Tokyo, Not set

Chungbuk National University Hospital ( Site 2802), Cheongju-si, Chungbuk

National Cancer Center ( Site 2800), Goyang-si, Kyonggi-do

The Catholic University of Korea St. Vincent s Hospital ( Site 2805), Gyeonggi-do, Kyonggi-do

Seoul National University Bundang Hospital ( Site 2801), Seongnam-si, Kyonggi-do

Ajou University Hospital ( Site 2803), Suwon-si, Kyonggi-do

Gyeongsang National University Hospital ( Site 2804), Jinju-si, Kyongsangnam-do

Keimyung University Dongsan Hospital ( Site 2807), Daegu, Taegu-Kwangyokshi

Kangbuk Samsung Hospital ( Site 2806), Seoul, Not set

Severance Hospital Yonsei University Health System ( Site 2808), Seoul, Not set

Pauls Stradins Clinical University Hospital ( Site 1501), Riga, Not set

Riga East Clinical University Hospital ( Site 1500), Riga, Not set

Hospital of Lithuanian University of Health Sciences Kauno klinikos-Pulmonology ( Site 4201), Kaunas, Kauno Apskritis

National Cancer Institute-Department of Thoracic Surgery and Oncology ( Site 4200), Vilnius, Vilniaus Miestas

Hospital Civil de Guadalajara Fray Antonio Alcalde ( Site 0500), Guadalajara, Jalisco

Hospital Universitario "Dr. Jose Eleuterio Gonzalez" ( Site 0508), Monterrey, Nuevo Leon

CLIMERS Clinical Medical Research ( Site 0506), Orizaba, Veracruz

Instituto Nacional de Cancerologia ( Site 0502), Tlalpan, Not set

Akershus Universitetssykehus HF ( Site 1106), Lorenskog, Akershus

Vestre Viken HF Drammen Sykehus ( Site 1101), Drammen, Buskerud

Sykehuset Oestfold ( Site 1107), Gralum, Ostfold

Helse Stavanger HF Stavanger Universitetssjukehus ( Site 1103), Stavanger, Rogaland

Oslo Universitetssykehus HF. Ulleval ( Site 1100), Oslo, Not set

Hospital Nacional Carlos Alberto Seguin Escobedo ESSALUD ( Site 0604), Arequipa, Ariqipa

Oncosalud ( Site 0605), Lima, Muni Metro De Lima

Detecta Clínica ( Site 0607), Surquillo, Muni Metro De Lima

IPOR Instituto Peruano de Oncología & Radioterapia ( Site 0606), Lima, Not set

Clinica San Gabriel ( Site 0601), Lima, Not set

Hospital Nacional Cayetano Heredia ( Site 0602), Lima, Not set

Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 2404), Siedlce, Mazowieckie

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (, Warszawa, Mazowieckie

Szpital Morski im. PCK. Szpitale Pomorskie Sp. Z o.o ( Site 2400), Gdynia, Pomorskie

SPZOZ MSWIA z Warminsko-Mazurskim Centrum Onkologii w Olsztynie ( Site 2401), Olsztyn, Warminsko-mazurskie

Spitalul Universitar de Urgenta Bucuresti ( Site 2508), Bucharest, Bucuresti

Gral Medical SRL-Medical Oncology ( Site 2511), București, Bucuresti

Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 2506), Cluj Napoca, Cluj

S.C. Radiotherapy Center Cluj S.R.L ( Site 2503), Comuna Floresti, Cluj

Centrul de Oncologie "Sfântul Nectarie"-Medical Oncology ( Site 2510), Craiova, Dolj

Radiology Therapeutic Center-Oncology ( Site 2502), Otopeni, Ilfov

Policlinica Oncomed SRL ( Site 2504), Timisoara, Timis

S C Oncocenter Oncologie Clinica S R L-Medical Oncology ( Site 2509), Timișoara, Timis

S.C.Focus Lab Plus S.R.L ( Site 2500), Bucuresti, Not set

Spitalul Clinic Judetean De Urgenta Constanta ( Site 2501), Constanta, Not set

Institutul Regional de Oncologie Iasi ( Site 2505), Iasi, Not set

Chelyabinsk Regional Clinical Oncological Dispensary ( Site 1913), Chelyabinsk, Chelyabinskaya Oblast

MSROI named after P.A. Hertsen branch of FSBI NMRC Radiology ( Site 1903), Moscow, Moskva

Nizhniy Novgorod Region Oncology Dispensary ( Site 1914), Nizhniy Novgorod, Nizhegorodskaya Oblast

Scientific Research Oncology Institute n.a. N.N.Petrov ( Site 1905), Saint-Petersburg, Sankt-Peterburg

Medical institute named after Berezin Sergey ( Site 1906), St. Petersburg, Sankt-Peterburg

Sverdlovsk Regional Oncology Hospital ( Site 1909), Ekaterinburg, Sverdlovskaya Oblast

Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1911), Kazan, Tatarstan, Respublika

Yaroslavl Regional SBIH Clinical Oncology Hospital ( Site 1910), Yaroslavl, Yaroslavskaya Oblast

Hospital Universitario Puerta de Hierro (Majadahonda) ( Site 1202), Majadahonda, Madrid

Hospital Universitario Quiron Madrid ( Site 1200), Pozuelo de Alarcon, Madrid

H.R.U Málaga - Hospital General ( Site 1206), Málaga, Malaga

H.U. Vall de Hebron ( Site 1201), Barcelona, Not set

Hospital Clinic de Barcelona ( Site 1204), Barcelona, Not set

Hospital Universitario Virgen Macarena ( Site 1205), Sevilla, Not set

Hospital Universitario La Fe ( Site 1203), Valencia, Not set

Chulalongkorn University ( Site 3003), Bangkok, Krung Thep Maha Nakhon

Ramathibodi Hospital. ( Site 3000), Bangkok, Krung Thep Maha Nakhon

Chiang Mai University Maharaj Nakorn Chiang Mai Hospital ( Site 3001), Chiang Mai, Not set

Srinagarind Hospital. Khon Kaen University ( Site 3002), Khon Kaen, Not set

Ankara Bilkent Sehir Hastanesi ( Site 2002), Ankara, Adana

Memorial Ankara Hastanesi ( Site 2006), Ankara, Not set

Istanbul Uni. Cerrahpasa Tip Fakultesi ( Site 2000), Istanbul, Not set

Medipol Universite Hastanesi ( Site 2003), Istanbul, Not set

Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi-oncology ( Site 2001), Istanbul, Not set

Ege University Medical Faculty ( Site 2005), Izmir, Not set

Medical center Medikal Plaza of Ecodnipro LLC ( Site 2107), Dnipro, Dnipropetrovska Oblast

SOGrigoriev Inst for Med Radiolgy and Oncology of NAMS of Ukraine-Clinical oncology and hematology (, Kharkiv, Kharkivska Oblast

Communal nonprofit enterprise "Kherson Regional Oncology Dispensary" of Kherson Regional Council (, Antonivka Village, Khersonska Oblast

LLC Ukrainian Center of Tomotherapy ( Site 2105), Kropyvnytskyi, Kirovohradska Oblast

Medical Center of Yuriy Spizhenko LLC.-Clinical Trial ( Site 2104), Kapitanivka Village, Kyivska Oblast

SNPE National Cancer Institute ( Site 2101), Kyiv, Kyivska Oblast

Medical Center Verum ( Site 2106), Kyiv, Kyivska Oblast

Kyiv City Clinical Oncology Center ( Site 2100), Kyiv, Not set

Weston Park Hospital ( Site 1406), Sheffield, Derbyshire

University College Hospital NHS Foundation Trust ( Site 1403), London-Camden, London, City Of

Guys and St Thomas NHS Foundation Trust ( Site 1410), London, London, City Of

Royal Marsden Hospital (Sutton) ( Site 1407), London, Surrey

Southampton General Hospital ( Site 1400), Southampton, Worcestershire

Leeds Teaching Hospitals NHS Trust ( Site 1401), Leeds, Not set

Christie NHS Foundation Trust ( Site 1409), Manchester, Not set

Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung

Learn More ›

Study of Cemiplimab - TP Induction Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck

NCT05376553

Enrolling By Invitation

The purpose of this research study is to determine the safety and tolerability of two dosing schedules of cemiplimab given in combination with cisplatin and docetaxel induction chemotherapy (TPI) in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN). Cemiplimab is FDA approved for treatment of basal cell and squamous cell carcinoma of the skin as well as non-small cell lung cancer but not for squamous cell carcinoma of head and neck.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/14/2024

Locations: Icahn School of Medicine at Mount Sinai, New York, New York

Conditions: Locally Advanced Head and Neck Squamous Cell Carcinoma

Learn More ›

Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)

NCT04956692

Active Not Recruiting

The purpose of this study is to evaluate pembrolizumab (MK-3475) subcutaneous (SC) administration as the first-line therapy in the treatment of metastatic squamous and nonsquamous NSCLC by assessing the pharmacokinetics (PK), safety, and efficacy of pembrolizumab SC injection in combination with standard-of-care chemotherapy. The primary hypothesis of the study is Pembrolizumab SC is noninferior to pembrolizumab intravenous (IV) for Cycle 1 Area Under Curve (AUC) and Cycle 6 minimal concentratio... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/14/2024

Locations: St. Bernards Medical Center ( Site 0103), Jonesboro, Arkansas +125 locations

St. Bernards Medical Center ( Site 0103), Jonesboro, Arkansas

St Joseph Heritage Healthcare-Oncology ( Site 0102), Fullerton, California

Cancer Blood and Specialty Clinic ( Site 0105), Los Alamitos, California

PIH Health Hematology Medical Oncology ( Site 0106), Whittier, California

Holy Cross Hospital ( Site 0017), Fort Lauderdale, Florida

Memorial Regional Hospital-Memorial Cancer Institute ( Site 0104), Hollywood, Florida

Advent Health ( Site 0013), Orlando, Florida

Fort Wayne Medical Oncology and Hematology ( Site 0101), Fort Wayne, Indiana

Baptist Health Lexington ( Site 0099), Lexington, Kentucky

St Luke's Hospital - Kansas City ( Site 0033), Kansas City, Missouri

St. Vincent Frontier Cancer Center ( Site 0058), Billings, Montana

Montefiore Medical Center [Bronx, NY] ( Site 0040), Bronx, New York

The University of Tennessee Medical Center ( Site 0050), Knoxville, Tennessee

Tennessee Oncology ( Site 0051), Nashville, Tennessee

Oncology Consultants, PA ( Site 0052), Houston, Texas

Millennium Physicians - Oncology ( Site 0097), Houston, Texas

Oncology & Hematology Assoc. SW Virginia, Inc., DBA Blue Ridge Cancer Care ( Site 0100), Blacksburg, Virginia

West Virginia University ( Site 0056), Morgantown, West Virginia

HOSPITAL EVANGÉLICO DE CACHOEIRO DE ITAPEMIRIM ( Site 0307), Cachoeiro de Itapemirim, Espirito Santo

Hospital Sao Vicente de Paulo ( Site 0311), Passo Fundo, Rio Grande Do Sul

Instituto Joinvilense de Hematologia e Oncologia ( Site 0308), Joinville, Santa Catarina

Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto ( Site 0305), Sao Jose do Rio Preto, Sao Paulo

Núcleo de Pesquisa Clínica da Rede São Camilo ( Site 0304), São Paulo, Sao Paulo

Nouvel Hôpital Civil (NHC) ( Site 1018), Strasbourg, Bas-Rhin

CHU Limoges CHU Dupuytren ( Site 1011), Limoges, Haute-Vienne

Hôpital Foch ( Site 1019), Suresnes, Hauts-de-Seine

Institut Regional du Cancer de Montpellier - ICM ( Site 1003), Montpellier, Herault

Centre Hospitalier Sud Réunion ( Site 1020), Saint-Pierre, La Reunion

Hopital Guillaume & Rene Laennec ( Site 1007), Saint-Herblain, Loire-Atlantique

Centre Hospitalier de Pau ( Site 1016), Pau, Pyrenees-Atlantiques

CHU de Rouen ( Site 1013), Rouen, Seine-Maritime

Hopital Cochin ( Site 1002), Paris, Not set

Centro de Investigaciones Clinicas de Latinoamerica S.A. - CELAN ( Site 0602), Guatemala, Not set

Clinica Privada Dr. Rixci Ramirez ( Site 0601), Guatemala, Not set

INTERVASC ( Site 0605), Guatemala, Not set

Grupo Angeles SA ( Site 0604), Guatemala, Not set

Centro Regional de Sub Especialidades Médicas SA ( Site 0600), Quetzaltenango, Not set

Bacs-Kiskun Megyei Korhaz-Onkoradiologiai Kozpont ( Site 1106), Kecskemét, Bacs-Kiskun

Petz Aladar Megyei Oktato Korhaz ( Site 1110), Gyor, Gyor-Moson-Sopron

Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz Rendelointezet ( Site 1103), Szolnok, Jasz-Nagykun-Szolnok

Tudogyogyintezet Torokbalint ( Site 1105), Torokbalint, Pest

Veszprem Megyei Tudogyogyintezet ( Site 1108), Farkasgyepu, Veszprem

Zala Megyei Szent Rafael Korhaz ( Site 1111), Zalagerszeg, Zalaegerszeg

Semmelweis University-Pulmonológiai Klinika ( Site 1114), Budapest, Not set

Orszagos Koranyi Pulmonologiai Intezet ( Site 1104), Budapest, Not set

Fujita Health University Hospital ( Site 3007), Toyoake, Aichi

Ehime University Hospital ( Site 3005), Toon, Ehime

Kurume University Hospital ( Site 3006), Kurume, Fukuoka

National Hospital Organization Hokkaido Cancer Center ( Site 3014), Sapporo, Hokkaido

Kanazawa University Hospital ( Site 3004), Kanazawa, Ishikawa

Kanagawa Cardiovascular and Respiratory Center ( Site 3003), Yokohama, Kanagawa

Miyagi Cancer Center ( Site 3000), Natori, Miyagi

Sendai Kousei Hospital ( Site 3015), Sendai, Miyagi

Kurashiki Central Hospital ( Site 3013), Kurashiki, Okayama

Kansai Medical University Hospital ( Site 3016), Hirakata, Osaka

National Hospital Organization Kinki-chuo Chest Medical Center ( Site 3009), Sakai, Osaka

Osaka Medical and Pharmaceutical University Hospital ( Site 3017), Takatsuki, Osaka

Chiba University Hospital ( Site 3008), Chiba, Not set

National Hospital Organization Kyushu Medical Center ( Site 3001), Fukuoka, Not set

National Hospital Organization Kyushu Cancer Center ( Site 3002), Fukuoka, Not set

Okayama University Hospital ( Site 3012), Okayama, Not set

Osaka International Cancer Institute ( Site 3018), Osaka, Not set

Tokushima University Hospital ( Site 3019), Tokushima, Not set

Juntendo University Hospital ( Site 3011), Tokyo, Not set

Showa University Hospital ( Site 3010), Tokyo, Not set

Chungnam National University Hospital ( Site 2002), Daejeon, Chungnam

Chonnam National University Hwasun Hospital-Pulmonology ( Site 2000), Hwasun, Jeonranamdo

Korea University Guro Hospital ( Site 2003), Seoul, Not set

Hospital Nacional Carlos Alberto Seguin Escobedo ESSALUD ( Site 0704), Arequipa, Ariqipa

Clínica Peruano-Americana de Trujillo ( Site 0701), Trujillo, La Libertad

Oncosalud ( Site 0706), Lima, Muni Metro De Lima

Clinica Internacional Sede San Borja ( Site 0705), Lima, Not set

Instituto Nacional de Enfermedades Neoplasicas ( Site 0703), Lima, Not set

Hospital Nacional Cayetano Heredia ( Site 0700), Lima, Not set

Centrum Onkologii im prof Franciszka Lukaszczyka ( Site 1201), Bydgoszcz, Kujawsko-pomorskie

Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 1206), Siedlce, Mazowieckie

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (, Warszawa, Mazowieckie

Centrum Pulmonologii i Torakochirurgii w Bystrej ( Site 1205), Bystra, Slaskie

Przychodnia Lekarska KOMED ( Site 1202), Konin, Wielkopolskie

Szpital Wojewodzki im. Mikolaja Kopernika ( Site 1200), Koszalin, Zachodniopomorskie

Cardiomed SRL Cluj-Napoca ( Site 1313), Cluj-Napoca, Cluj

Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 1303), Cluj-Napoca, Cluj

SC Radiotherapy Center Cluj SRL ( Site 1307), Comuna Floresti, Cluj

S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 1304), Craiova, Dolj

Centrul de Oncologie Oncolab-Medical Oncology ( Site 1312), Craiova, Dolj

Spitalul Municipal Ploiesti ( Site 1308), Ploiesti, Prahova

Policlinica Oncomed SRL ( Site 1302), Timisoara, Timis

S.C.Focus Lab Plus S.R.L ( Site 1301), Bucuresti, Not set

Spitalul Universitar de Urgenta Bucuresti ( Site 1305), Bucuresti, Not set

SPBU Clinic of Advanced medical technologies n.a. N. I. Pirogov ( Site 1406), Saint-Petersburg, Sankt-Peterburg

National Medical Research Center of Oncology N.A. N.N. Petrov ( Site 1407), Saint-Petersburg, Sankt-Peterburg

Saint-Petersburg Scientific-Practical Center of Specialized Kinds of Medical Care (o) ( Site 1424), Saint-Petersburg, Sankt-Peterburg

Republican Clinical Oncology Dispensary-Chemotherapy #1 ( Site 1425), Kazan, Tatarstan, Respublika

SPb SBHI City Clinical Oncological Dispensary ( Site 1409), Sankt-Peterburg, Not set

Wits Clinical Research ( Site 1510), Johannesburg, Gauteng

Steve Biko Academic Hospital ( Site 1506), Pretoria, Gauteng

Marry Potter Oncology Centre ( Site 1502), Pretoria, Gauteng

Sandton Oncology Medical Group PTY LTD ( Site 1505), Sandton, Gauteng

Chris Hani Baragwanath Academic Hospital-Wits Clinical Research Bara ( Site 1513), Soweto, Gauteng

The Oncology Centre ( Site 1507), Durban, Limpopo

Cape Town Oncology Trials Pty Ltd ( Site 1500), Kraaifontein, Western Cape

Hospital Insular de Gran Canaria-Oncology ( Site 1604), Las Palmas de Gran Canaria, Las Palmas

H.U. Vall de Hebron ( Site 1600), Barcelona, Not set

Hospital Juan Ramon Jimenez ( Site 1602), Huelva, Not set

Hospital Universitario Lucus Augusti ( Site 1603), Lugo, Not set

Hospital Universitario La Paz ( Site 1601), Madrid, Not set

Changhua Christian Hospital ( Site 2104), Changhua, Not set

National Taiwan University Hospital Hsin-Chu Branch ( Site 2103), Hsinchu, Not set

Kaohsiung Medical University Chung-Ho Memorial Hospital ( Site 2107), Kaohsiung, Not set

National Cheng Kung University Hospital ( Site 2105), Tainan, Not set

National Taiwan University Hospital ( Site 2101), Taipei, Not set

Taipei Veterans General Hospital ( Site 2106), Taipei, Not set

Chang Gung Medical Foundation-Linkou Branch ( Site 2102), Taoyuan, Not set

Gulhane Egitim ve Arastirma Hastanesi ( Site 1704), Ankara, Not set

Ankara Sehir Hastanesi ( Site 1702), Ankara, Not set

TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1701), Istanbul, Not set

Ege Universitesi Tip Fakultesi Hastanesi ( Site 1703), Izmir, Not set

Inonu Universitesi Turgut Ozal Tip Merkezi ( Site 1707), Malatya, Not set

Medical Center Mriya Med-Service ( Site 1805), Kryvyi Rih, Dnipropetrovska Oblast

Communal non profit enterprise Regional Clinical Oncology Center ( Site 1806), Kharkiv, Kharkivska Oblast

Ukrainian Center of Tomotherapy ( Site 1807), Kropyvnytskyi, Kirovohradska Oblast

Medical Center Asklepion LLC ( Site 1804), Khodosivka, Kyivska Oblast

Municipal non-profit enterprise'Odesa Regional Clinical Hosp-Thoracic surgery department. ( Site 181, Odesa, Odeska Oblast

Kremenchuk Regional Oncology Center ( Site 1811), Kremenchuk, Poltavska Oblast

Kyiv City Clinical Oncology Centre ( Site 1809), Kyiv, Not set

Medical Center Dobrobut Clinic ( Site 1808), Kyiv, Not set

Conditions: Non-Small Cell Lung Cancer

Learn More ›

Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)

NCT03425643

Active Not Recruiting

This trial will evaluate the safety and efficacy of pembrolizumab (MK-3475) in combination with platinum doublet neoadjuvant chemotherapy (NAC) before surgery \[neoadjuvant phase\], followed by pembrolizumab alone after surgery \[adjuvant phase\] in participants with resectable stage II, IIIA, and resectable IIIB (T3-4N2) non-small cell lung cancer (NSCLC). The primary hypotheses of this study are that neoadjuvant pembrolizumab (vs. placebo) in combination with NAC, followed by surgery and adjuv... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/14/2024

Locations: Banner MD Anderson Cancer Center ( Site 0028), Gilbert, Arizona +226 locations

Banner MD Anderson Cancer Center ( Site 0028), Gilbert, Arizona

Western Regional Medical Center, Inc. ( Site 0050), Goodyear, Arizona

University of Arizona Cancer Center - Dignity Health ( Site 0062), Phoenix, Arizona

University of Arizona Cancer Center ( Site 0012), Tucson, Arizona

Pacific Cancer Medical Center, Inc. ( Site 0004), Anaheim, California

Providence Saint Joseph Medical Center ( Site 0061), Burbank, California

Pacific Cancer Care ( Site 0035), Monterey, California

John Wayne Cancer Institute ( Site 0049), Santa Monica, California

St Joseph Heritage Healthcare ( Site 0040), Santa Rosa, California

Stanford University, Stanford Cancer Center ( Site 0046), Stanford, California

Hartford Hospital ( Site 0069), Hartford, Connecticut

Helen F. Graham Cancer Center & Research Institute ( Site 0015), Newark, Delaware

Mayo Clinic Jacksonville ( Site 0022), Jacksonville, Florida

Miami Cancer Institute-Baptist Hospital ( Site 0068), Miami, Florida

Southeastern Regional Medical Center ( Site 0051), Newnan, Georgia

Northwest Oncology and Hematology ( Site 0001), Elk Grove Village, Illinois

Ingalls Memorial Hospital ( Site 0044), Harvey, Illinois

PPG-Oncology ( Site 0043), Fort Wayne, Indiana

University of Iowa Hospital and Clinics ( Site 0010), Iowa City, Iowa

Ashland-Bellefonte Cancer Center ( Site 0021), Ashland, Kentucky

Harry & Jeanette Weinberg Cancer Institute ( Site 0081), Baltimore, Maryland

Boston Medical Center ( Site 0057), Boston, Massachusetts

UMass Memorial Medical Center ( Site 0030), Worcester, Massachusetts

Henry Ford Health System ( Site 0031), Detroit, Michigan

Herbert Herman Cancer Center, Sparrow Hospital ( Site 0034), Lansing, Michigan

Mayo Clinic ( Site 0026), Rochester, Minnesota

St. Vincent Healthcare Frontier Cancer Center ( Site 0005), Billings, Montana

University of Nebraska Medical Center ( Site 0047), Omaha, Nebraska

Memorial Sloan Kettering Cancer Center Basking Ridge ( Site 0074), Basking Ridge, New Jersey

Memorial Sloan Kettering Cancer Center- Monmouth ( Site 0077), Middletown, New Jersey

MSKCC-Bergen ( Site 0075), Montvale, New Jersey

St. Peter's Hospital Cancer Care Center ( Site 0039), Albany, New York

Montefiore Einstein Center ( Site 0016), Bronx, New York

Memorial Sloan-Kettering Cancer Center at Commack ( Site 0076), Commack, New York

Memorial Sloan Kettering Cancer Center Westchester ( Site 0079), Harrison, New York

Memorial Sloan Kettering Cancer Center ( Site 0060), New York, New York

Stony Brook University Medical Center - Cancer Center ( Site 0019), Stony Brook, New York

Memorial Sloan Kettering Cancer Center - Nassau ( Site 0078), Uniondale, New York

White Plains Hospital Center for Cancer Care ( Site 0007), White Plains, New York

Southwestern Regional Medical Center, Inc. ( Site 0054), Tulsa, Oklahoma

OHSU Center for Health & Healing ( Site 1006), Portland, Oregon

UPMC Pinnacle Health System - East Location ( Site 0063), Harrisburg, Pennsylvania

Cancer Treatment Centers of America-Eastern Regional Medical Center ( Site 0053), Philadelphia, Pennsylvania

Allegheny General Hospital ( Site 0009), Pittsburgh, Pennsylvania

UPMC Hillman Cancer Centers ( Site 0041), Pittsburgh, Pennsylvania

VA Pittsburgh Healthcare System ( Site 0052), Pittsburgh, Pennsylvania

Saint Francis Cancer Center ( Site 0096), Greenville, South Carolina

Emily Couric Clinical Cancer Center ( Site 0013), Charlottesville, Virginia

Inova Schar Cancer Institute ( Site 0032), Fairfax, Virginia

Virginia Cancer Specialists, PC ( Site 0080), Fairfax, Virginia

Providence Regional Cancer Partnership ( Site 0065), Everett, Washington

Centro de Oncologia e Investigacion Buenos Aires COIBA ( Site 0136), Berazategui, Buenos Aires

Hospital Privado de Comunidad. ( Site 0130), Mar del Plata, Buenos Aires

Hospital Universitario Austral ( Site 0127), Pilar, Buenos Aires

Fundacion Favaloro ( Site 0128), Ciudad de Buenos Aires, Caba

Sanatorio Britanico ( Site 0125), Rosario, Santa Fe

Sanatorio Parque ( Site 0135), Rosario, Santa Fe

Hospital Provincial del Centenario ( Site 0131), Rosario, Santa Fe

Hospital Privado Universitario de Córdoba ( Site 0139), Cordoba, Not set

Sanatorio Allende ( Site 0129), Cordoba, Not set

CER San Juan Centro Polivalente de Asistencia e Investigacion Clinica ( Site 0133), San Juan, Not set

Orange Health Services ( Site 0624), Orange, New South Wales

Westmead Hospital ( Site 0621), Westmead, New South Wales

AZ Sint-Maarten ( Site 0226), Mechelen, Antwerpen

Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman ( Site 0223), Liège, Liege

UZ Gent ( Site 0224), Gent, Oost-Vlaanderen

AZ Nikolaas ( Site 0225), Sint-Niklaas, Oost-Vlaanderen

UZ Leuven ( Site 0221), Leuven, Vlaams-Brabant

AZ Delta ( Site 0222), Roeselare, West-Vlaanderen

Centro Regional Integrado de Oncologia ( Site 0160), Fortaleza, Ceara

Instituto do Cancer do Ceara ( Site 0152), Fortaleza, Ceara

Sirio-Libanes Brasilia - Centro de Oncologia - Asa Sul ( Site 0159), Brasilia, Distrito Federal

Liga Norte Riograndense Contra o Cancer ( Site 0150), Natal, Rio Grande Do Norte

Hospital de Caridade de Ijui ( Site 0153), Ijui, Rio Grande Do Sul

Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da Pucrs ( Site 0146), Porto Alegre, Rio Grande Do Sul

Hospital Nossa Senhora da Conceicao ( Site 0145), Porto Alegre, Rio Grande Do Sul

YNOVA Pesquisa Clinica ( Site 0823), Florianopolis, Santa Catarina

Fundacao Pio XII - Hospital de Cancer de Barretos ( Site 0144), Barretos, Sao Paulo

Instituto Nacional do Cancer Jose Alencar Gomes da Silva INCA ( Site 0149), Rio de Janeiro, Not set

Hospital Paulistano - Amil Clinical Research ( Site 0822), Sao Paulo, Not set

Hospital Alemao Oswaldo Cruz ( Site 0158), Sao Paulo, Not set

Princess Margaret Cancer Centre ( Site 0109), Toronto, Ontario

CIUSSS du Saguenay-Lac-St-Jean ( Site 0101), Chicoutimi, Quebec

Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0110), Montreal, Quebec

CIUSSS Ouest de l Ile - St-Mary s Hospital ( Site 0104), Montreal, Quebec

McGill University Health Centre ( Site 0111), Montreal, Quebec

Tianjin Medical University General Hospital ( Site 0806), Tianjin, Anhui

Beijing Cancer Hospital ( Site 0810), Beijing, Beijing

Beijing Cancer Hospital ( Site 0811), Beijing, Beijing

Cancer Hospital Chinese Academy of Medical Sciences ( Site 0801), Beijing, Beijing

Peking University Third Hospital ( Site 0812), Beijing, Beijing

Peking Union Medical College Hospital ( Site 0809), Beijing, Beijing

Sun Yat-Sen University Cancer Center ( Site 0816), Guangzhou, Guangdong

Hunan Cancer Hospital ( Site 0815), Changsha, Hunan

Fudan University Shanghai Cancer Center ( Site 0813), Shanghai, Shanghai

Zhongshan Hospital of Fudan University ( Site 0808), Shanghai, Shanghai

Shanghai Pulmonary Hospital-Thoracic Surgery department ( Site 0817), Shanghai, Shanghai

Tang Du Hospital ( Site 0803), XI An, Shanxi

The First Affiliated Hospital of Zhejiang University ( Site 0804), Hangzhou, Zhejiang

Zhejiang Cancer Hospital.... ( Site 0814), Hangzhou, Zhejiang

Hwa Mei Hospital University of Chinese Academy of Sciences ( Site 0802), Ningbo, Zhejiang

SA Pohja-Eesti Regionaalhaigla ( Site 1100), Tallinn, Harjumaa

Hopital Foch ( Site 0243), Suresnes, Ain

Nouvel Hopital Civil ( Site 0255), Strasbourg, Bas-Rhin

CHU de Toulouse - Hopital Larrey ( Site 0258), Toulouse, Haute-Garonne

Clinique Francois Chenieux ( Site 0246), Limoges, Haute-Vienne

Hospices Civils de Lyon Centre Hospitalier Lyon Sud ( Site 0241), Pierre-Benite, Rhone-Alpes

Centre Hospitalier Metropole Savoie Site de Chambery ( Site 0245), Chambery, Savoie

Centre Hospitalier Annecy Genevois ( Site 0242), Pringy, Savoie

CHU de Rouen ( Site 0252), Rouen, Seine-Maritime

Hôpital Avicenne - Service d oncologie medicale ( Site 0249), Bobigny, Seine-Saint-Denis

H.I.A. Sainte-Anne ( Site 0251), Toulon, Var

Institut Curie ( Site 0250), Paris, Not set

Klinikum Esslingen GmbH ( Site 0875), Esslingen, Baden-Wurttemberg

LKI Lungenfachklinik Immenhausen ( Site 0268), Immenhausen, Hessen

Florence Nightingale Krankenhaus ( Site 0874), Duesseldorf, Nordrhein-Westfalen

Lungenklinik Hemer ( Site 0269), Hemer, Nordrhein-Westfalen

Mathias Spital Rheine ( Site 0261), Rheine, Nordrhein-Westfalen

Katholisches Klinikum Koblenz Haus Marienhof ( Site 0873), Koblenz, Rheinland-Pfalz

Universitaetsklinikum Carl Gustav Carus ( Site 0273), Dresden, Sachsen

Universitaetsklinikum Leipzig AOeR ( Site 0277), Leipzig, Sachsen

LungenClinic Grosshansdorf GmbH ( Site 0267), Grosshansdorf, Schleswig-Holstein

Universitaetsklinikum Schleswig Holstein ( Site 0871), Kiel, Schleswig-Holstein

Zentralklinik Bad Berka GmbH ( Site 0264), Bad Berka, Thuringen

SRH Waldklinikum Gera GmbH ( Site 0272), Gera, Thuringen

Evangelische Lungenklinik Berlin ( Site 0274), Berlin, Not set

HELIOS Klinikum Emil von Behring ( Site 0280), Berlin, Not set

Asklepios Klinikum Hamburg ( Site 0271), Hamburg, Not set

Cork University Hospital ( Site 0452), Wilton, Cork

St James Hospital ( Site 0451), Dublin, Not set

Mid Western Cancer Centre ( Site 0450), Limerick, Not set

Istituto Nazionale Tumori ( Site 0309), Milano, Abruzzo

Azienda Ospedaliera dei Colli V. Monaldi ( Site 0301), Napoli, Campania

IRST-Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori ( Site 0300), Meldola, Forli-Cesena

Istituto Clinico Humanitas Research Hospital ( Site 0314), Rozzano, Lombardia

ASST Grande Ospedale Metropolitano Niguarda-Oncologia Falck ( Site 0315), Milan, Milano

Azienda Ospedaliera San Gerardo ( Site 0308), Monza, Monza E Brianza

AOU San Luigi Gonzaga di Orbassano ( Site 0313), Orbassano, Torino

Azienda Ospedaliera Spedali Civili di Brescia ( Site 0307), Brescia, Not set

IRCCS Ospedale San Raffaele di Milano ( Site 0303), Milano, Not set

Azienda Ospedaliera San Camillo Forlanini ( Site 0311), Roma, Not set

Aichi Cancer Center Hospital ( Site 0765), Nagoya, Aichi

National Cancer Center Hospital East ( Site 0761), Kashiwa, Chiba

HP of the Univ. of Occupational and Environmental Health, Japan ( Site 0770), Kitakyushu, Fukuoka

Hyogo Cancer Center ( Site 0764), Akashi, Hyogo

St. Marianna University School of Medicine Hospital ( Site 0769), Kawasaki, Kanagawa

Kanagawa Cancer Center ( Site 0763), Yokohama, Kanagawa

Oita University Hospital ( Site 0766), Yufu, Oita

Fukushima Medical University Hospital ( Site 0772), Fukushima, Not set

Hiroshima University Hospital ( Site 0762), Hiroshima, Not set

National Cancer Center Hospital ( Site 0767), Tokyo, Not set

Juntendo University Hospital ( Site 0768), Tokyo, Not set

Tokyo Medical University Hospital ( Site 0771), Tokyo, Not set

National Cancer Center ( Site 0702), Gyeonggi-do, Kyonggi-do

The Catholic University of Korea St. Vincent s Hospital ( Site 0705), Gyeonggi-do, Kyonggi-do

Asan Medical Center ( Site 0701), Seoul, Not set

Samsung Medical Center ( Site 0704), Seoul, Not set

SMG-SNU Boramae Medical Center ( Site 0707), Seoul, Not set

Pauls Stradins Clinical University Hospital ( Site 0911), Riga, Not set

Riga East Clinical University Hospital ( Site 0912), Riga, Not set

LSMUL Kauno Klinikos ( Site 0932), Kaunas, Not set

Nacionalinis Vezio Institutas ( Site 0931), Vilnius, Not set

Sarawak General Hospital ( Site 0782), Kuching, Sarawak

University Malaya Medical Centre ( Site 0781), Kuala Lumpur, Not set

Centrum Pulmonologii i Torakochirurgii w Bystrej ( Site 0484), Bystra, Dolnoslaskie

Dolnoslaskie Centrum Onkologii. ( Site 0491), Wroclaw, Dolnoslaskie

Centrum Onkologii im. Prof. Franciszka Lukaszczyka ( Site 0488), Bydgoszcz, Kujawsko-pomorskie

Wojewodzki Szpital Specjalistyczny im. M. Kopernika w Lodzi ( Site 0493), Lodz, Lodzkie

Szpital Specjalistyczny w Prabutach Sp. z o.o. ( Site 0483), Prabuty, Pomorskie

Wielkopolskie Centrum Pulmonologii i Torakochirurgii ( Site 0487), Poznan, Wielkopolskie

S C Pelican Impex SRL ( Site 0506), Oradea, Bihor

Centrul Medical Medicover Victoria ( Site 0514), Bucharest, Bucuresti

Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 0501), Cluj Napoca, Cluj

Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 0515), Cluj-Napoca, Cluj

SC Radiotherapy Center Cluj SRL ( Site 0509), Comuna Floresti, Cluj

S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 0504), Craiova, Dolj

S.C.R.T.C.Radiology Therapeutic Center SRL ( Site 0511), Otopeni, Ilfov

S C Oncocenter Oncologie Medicala S R L ( Site 0505), Timisoara, Timis

Spitalul Sf. Constantin ( Site 0512), Brasov, Not set

Euroclinic Hospital Bucharest ( Site 0510), Bucuresti, Not set

S.C.Focus Lab Plus S.R.L ( Site 0513), Bucuresti, Not set

Spitalul clinic Judetean de urgenta Constanta ( Site 0508), Constanta, Not set

Spitalul Judetean de Urgenta .Sf. Ioan cel Nou. ( Site 0503), Suceava, Not set

Chelyabinsk Regional Clinical Oncological Dispensary ( Site 0530), Chelyabinsk, Chelyabinskaya Oblast

N.N. Blokhin NMRCO ( Site 0521), Moscow, Moskva

National Medical Research Radiology Centre ( Site 0535), Moscow, Moskva

Medical Rehabilitation Center ( Site 0534), Moscow, Moskva

SBHI Leningrad Regional Clinical Hospital ( Site 0524), Saint Petersburg, Sankt-Peterburg

Scientific Research Oncology Institute n.a. N.N.Petrov ( Site 0533), Saint Petersburg, Sankt-Peterburg

Municipal Clinical Oncology Center ( Site 0523), Saint Petersburg, Sankt-Peterburg

Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 0529), Kazan, Tatarstan, Respublika

Tomsk Scientific Research Institute of Oncology ( Site 0526), Tomsk, Tomskaya Oblast

Wits Clinical Research ( Site 0570), Parktown-Johannesburg, Gauteng

Wilgers Oncology Centre ( Site 0573), Pretoria, Gauteng

The Oncology Centre ( Site 0571), Durban, Kwazulu-Natal

Cape Town Oncology Trials Pty Ltd ( Site 0572), Kraaifontein, Western Cape

Hospital Germans Trias i Pujol. ICO de Badalona ( Site 0381), Badalona, Barcelona

Instituto Catalan de Oncologia - ICO ( Site 0388), L Hospitalet De Llobregat, Barcelona

Hospital Universitario de Girona Doctor Josep Trueta ( Site 0386), Girona, La Coruna

Hospital Universitario Insular de Gran Canaria ( Site 0383), Las Palmas de Gran Canaria, Las Palmas

Hospital de la Santa Creu i Sant Pau ( Site 0385), Barcelona, Not set

Hospital Universitari Vall d Hebron ( Site 0389), Barcelona, Not set

Hospital General Universitario Gregorio Maranon ( Site 0382), Madrid, Not set

Hospital Virgen del Rocio ( Site 0387), Sevilla, Not set

Kaohsiung Chang Gung Memorial Hospital ( Site 0725), Kaohsiung, Not set

China Medical University Hospital ( Site 0724), Taichung, Not set

National Taiwan University Hospital ( Site 0721), Taipei, Not set

Taipei Veterans General Hospital ( Site 0722), Taipei, Not set

Tri-Service General Hospital ( Site 0726), Taipei, Not set

Chang Gung Medical Foundation.Linkou Branch ( Site 0723), Taoyuan, Not set

Cherkassy Regional Oncological Center ( Site 0613), Cherkasy, Cherkaska Oblast

City Clinical Hosp.4 of DCC ( Site 0607), Dnipro, Dnipropetrovska Oblast

MI Precarpathian Clinical Oncology Center ( Site 0603), Ivano-Frankivsk, Ivano-Frankivska Oblast

MI KhRC Kherson Regional Oncology Dispensary ( Site 0614), Kherson, Khersonska Oblast

PP PPC Acinus Medical and Diagnostic Centre ( Site 0609), Kropyvnytsky, Kirovohradska Oblast

National Cancer Institute of the MoH of Ukraine ( Site 0605), Kyiv, Kyivska Oblast

Kyiv City Clinical Oncological Center ( Site 0601), Kyiv, Kyivska Oblast

MI Odessa Regional Oncological Centre ( Site 0608), Odesa, Odeska Oblast

Zaporizhzhya Regional Clinical Oncology Center ( Site 0606), Zaporizhzhya, Zaporizka Oblast

Leicester Royal Infirmary ( Site 0447), Leicester, Leicestershire

The Clatterbridge Cancer Centre NHS Foundation Trust ( Site 0456), Wirral, Liverpool

Royal Marsden NHS Foundation Trust ( Site 0458), London, London, City Of

Royal Marsden Hospital ( Site 0457), Sutton, London, City Of

Nottingham City Hospital Campus ( Site 0441), Nottingham, Nottinghamshire

Heartlands Hospital in Birmingham ( Site 0455), Birmingham, Not set

Freeman Hospital ( Site 0444), Newcastle upon Tyne, Not set

Plymouth Hospitals NHS Trust ( Site 0443), Plymouth, Not set

Conditions: Non-small Cell Lung Cancer

Learn More ›

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

NCT02009449

Completed

This is a first-in-human, open-label, dose escalation study to evaluate the safety and tolerability of pegilodecakin in participants with advanced solid tumors, dosed daily subcutaneously as a monotherapy or in combination with chemotherapy or immunotherapy.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/13/2024

Locations: UCLA Medical Hematology & Oncology, Los Angeles, California +9 locations

Conditions: Melanoma, Prostate Cancer, Ovarian Cancer, Renal Cell Carcinoma, Colorectal Carcinoma, Pancreatic Carcinoma, Non-small Cell Lung Carcinoma, Solid Tumors, Breast Cancer

Learn More ›

Browse by State

Cisplatin treatment options in Alabama

Cisplatin treatment options in Alaska

Cisplatin treatment options in Arizona

Cisplatin treatment options in Arkansas

Cisplatin treatment options in California

Cisplatin treatment options in Colorado

Cisplatin treatment options in Connecticut

Cisplatin treatment options in Delaware

Cisplatin treatment options in District of Columbia

Cisplatin treatment options in Florida

Cisplatin treatment options in Georgia

Cisplatin treatment options in Hawaii

Cisplatin treatment options in Idaho

Cisplatin treatment options in Illinois

Cisplatin treatment options in Indiana

Cisplatin treatment options in Iowa

Cisplatin treatment options in Kansas

Cisplatin treatment options in Kentucky

Cisplatin treatment options in Louisiana

Cisplatin treatment options in Maine

Cisplatin treatment options in Montana

Cisplatin treatment options in Nebraska

Cisplatin treatment options in Nevada

Cisplatin treatment options in New Hampshire

Cisplatin treatment options in New Jersey

Cisplatin treatment options in New Mexico

Cisplatin treatment options in New York

Cisplatin treatment options in North Carolina

Cisplatin treatment options in North Dakota

Cisplatin treatment options in Ohio

Cisplatin treatment options in Oklahoma

Cisplatin treatment options in Oregon

Cisplatin treatment options in Maryland

Cisplatin treatment options in Massachusetts

Cisplatin treatment options in Michigan

Cisplatin treatment options in Minnesota

Cisplatin treatment options in Mississippi

Cisplatin treatment options in Missouri

Cisplatin treatment options in Pennsylvania

Cisplatin treatment options in Rhode Island

Cisplatin treatment options in South Carolina

Cisplatin treatment options in South Dakota

Cisplatin treatment options in Tennessee

Cisplatin treatment options in Texas

Cisplatin treatment options in Utah

Cisplatin treatment options in Vermont

Cisplatin treatment options in Virginia

Cisplatin treatment options in Washington

Cisplatin treatment options in West Virginia

Cisplatin treatment options in Wisconsin

Cisplatin treatment options in Wyoming